These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10785486)
1. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report. Rose PG; Shrigley R; Wiesner GL Gynecol Oncol; 2000 May; 77(2):319-20. PubMed ID: 10785486 [TBL] [Abstract][Full Text] [Related]
2. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Paley PJ; Swisher EM; Garcia RL; Agoff SN; Greer BE; Peters KL; Goff BA Gynecol Oncol; 2001 Feb; 80(2):176-80. PubMed ID: 11161856 [TBL] [Abstract][Full Text] [Related]
3. BRCA2 germline mutations in primary cancer of the fallopian tube. Casarsa S; Puglisi F; Baudi F; De Paola L; Venuta S; Piga A; Di Loreto C; Marchesoni D; D'Elia AV; Damante G Oncol Rep; 2004 Aug; 12(2):313-6. PubMed ID: 15254695 [TBL] [Abstract][Full Text] [Related]
4. A genetic epidemiological study of carcinoma of the fallopian tube. Aziz S; Kuperstein G; Rosen B; Cole D; Nedelcu R; McLaughlin J; Narod SA Gynecol Oncol; 2001 Mar; 80(3):341-5. PubMed ID: 11263928 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube. Vicus D; Finch A; Cass I; Rosen B; Murphy J; Fan I; Royer R; McLaughlin J; Karlan B; Narod SA Gynecol Oncol; 2010 Sep; 118(3):299-302. PubMed ID: 20570322 [TBL] [Abstract][Full Text] [Related]
7. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Zweemer RP; van Diest PJ; Verheijen RH; Ryan A; Gille JJ; Sijmons RH; Jacobs IJ; Menko FH; Kenemans P Gynecol Oncol; 2000 Jan; 76(1):45-50. PubMed ID: 10620440 [TBL] [Abstract][Full Text] [Related]
8. [Carcinoma of the fallopian tube after prophylactic laparoscopic ovariectomy in a patient with a BRCAI mutation]. Dijkhuizen FP; Huisman A; Boonstra H; Aalders AL Ned Tijdschr Geneeskd; 2003 May; 147(18):877-9. PubMed ID: 12756880 [TBL] [Abstract][Full Text] [Related]
9. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Goshen R; Chu W; Elit L; Pal T; Hakimi J; Ackerman I; Fyles A; Mitchell M; Narod SA Gynecol Oncol; 2000 Dec; 79(3):477-81. PubMed ID: 11104623 [TBL] [Abstract][Full Text] [Related]
10. Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy. McEwen AR; McConnell DT; Kenwright DN; Gaskell DJ; Cherry A; Kidd AM Gynecol Oncol; 2004 Mar; 92(3):992-4. PubMed ID: 14984974 [TBL] [Abstract][Full Text] [Related]
11. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Rabban JT; Crawford B; Chen LM; Powell CB; Zaloudek CJ Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124 [TBL] [Abstract][Full Text] [Related]
12. A novel germline in frame deletion (4128del3) of the BRCA2 gene detected in a breast/ovarian cancer family with fallopian tube and brain tumors identified in the north of France. Demange L; Noguchi T; Sauvan R; Moyal-Amsellem N; Birnbaum D; Eisinger F; Sobol H Hum Mutat; 2001 Feb; 17(2):155. PubMed ID: 11180606 [No Abstract] [Full Text] [Related]
13. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312 [TBL] [Abstract][Full Text] [Related]
14. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Rabban JT; Krasik E; Chen LM; Powell CB; Crawford B; Zaloudek CJ Am J Surg Pathol; 2009 Dec; 33(12):1878-85. PubMed ID: 19898224 [TBL] [Abstract][Full Text] [Related]
16. Risk of endometrial carcinoma associated with BRCA mutation. Levine DA; Lin O; Barakat RR; Robson ME; McDermott D; Cohen L; Satagopan J; Offit K; Boyd J Gynecol Oncol; 2001 Mar; 80(3):395-8. PubMed ID: 11263938 [TBL] [Abstract][Full Text] [Related]
17. BRCA: the breast, ovarian, and other cancer genes. Boyd J Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927 [No Abstract] [Full Text] [Related]
18. Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Sonoda Y; Saigo PE; Federici MG; Boyd J Gynecol Oncol; 2000 Feb; 76(2):226-9. PubMed ID: 10637076 [TBL] [Abstract][Full Text] [Related]
19. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families. Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759 [TBL] [Abstract][Full Text] [Related]